ME Therapeutics Holdings Inc.
METX
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -219.10K | -227.90K | -364.00K | -106.80K | -251.30K |
| Total Depreciation and Amortization | 7.60K | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 113.00K | 124.80K | 225.10K | 7.30K | 155.30K |
| Change in Net Operating Assets | -7.20K | -6.60K | 33.90K | 25.60K | -98.40K |
| Cash from Operations | -105.70K | -109.70K | -104.90K | -73.90K | -194.40K |
| Capital Expenditure | -6.40K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.90K | -- | -- | -- | -- |
| Cash from Investing | -14.30K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.40K | 0.00 | 0.00 | -40.00K | -- |
| Issuance of Common Stock | -- | 0.00 | 450.00K | 1.11M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -7.50K | -- | -- | -- |
| Cash from Financing | -4.00K | -5.50K | 330.20K | 792.70K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -124.00K | -115.20K | 225.30K | 718.80K | -194.40K |
